AstraZeneca PLC (AZN)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $286.07B
Last updated: Nov 17, 2026 at 4:43 PM ET
AstraZeneca PLC (AZN) Stock Chart
AstraZeneca (AZN) has a latest price of $182.36 on Nov 17, 2026, 12.8% below its 52-week high of $209.11. Its price rose 4.5% over the past 12 months. The month-end price rose 229.5% over the 10 years through Oct 2026, a compound annual rate of 12.7%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $208.45 in Feb 2026 and its lowest $52.28 in Nov 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart AZN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for AZN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 10.6%, and over 6 months it fell 0.6%. The month-end price rose 47.6% over the 3 years through Oct 2026, a compound annual rate of 13.9%.
| Period | Change |
|---|---|
| 1 month | +11.2% |
| 3 months | +10.6% |
| 6 months | -0.6% |
| 12 months | +4.5% |
| 12 months, with dividends | +7.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +47.6% | +13.9% |
| 5 years | +49.6% | +8.4% |
| 10 years | +229.5% | +12.7% |
Price by Year
Its best calendar year was 2025, when the price rose 40.3%, and its weakest was 2024, when it fell 2.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $186.65 | +1.5% |
| 2025 | $183.86 | +40.3% |
| 2024 | $131.04 | -2.7% |
| 2023 | $134.70 | -0.7% |
| 2022 | $135.60 | +16.4% |
| 2021 | $116.50 | +16.5% |
| 2020 | $99.98 | +0.3% |
| 2019 | $99.72 | +31.3% |
| 2018 | $75.96 | +9.5% |
| 2017 | $69.40 | +27.0% |
Trading Range
The price is 7.5% above its 50-day average of $169.68 and 1.7% above its 200-day average of $179.34.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $182.36 | |
| 52-week high | $209.11 | -12.8% |
| 52-week low | $152.40 | +19.7% |
| 50-day average | $169.68 | +7.5% |
| 200-day average | $179.34 | +1.7% |
Price Risk
Over 3 years, its largest fall from a peak was 27.9%.
| Measure | Value |
|---|---|
| 1-year beta | 0.22 |
| Largest fall, 1 year | -25.8% |
| Largest fall, 3 years | -27.9% |
Valuation
AstraZeneca traded at 30.9x earnings at the end of 2025, against a 5-year median of 37.6x and a 10-year median of 39.7x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About AZN
What is AZN's 1-year price change?
AstraZeneca's price rose 4.5% over the past 12 months. With dividends included, the 12-month total return was 7.6%.
What is AZN's 5-year price change?
AstraZeneca's month-end price rose 49.6% over the 5 years through Oct 2026, a compound annual rate of 8.4%. These figures leave out dividends.
What is AZN's 52-week high and low?
AstraZeneca's 52-week high is $209.11 and its 52-week low is $152.40. Its latest price of $182.36 on Nov 17, 2026 is 12.8% below the high.
What is AZN's beta?
AstraZeneca's 1-year beta against the S&P 500 is 0.22, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 25.8%.
Is the AZN chart free?
Yes. Advanced Charting for AZN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
AZN pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts